Prevalence of Viral Hepatitis B, C, and D in Kazakhstan

Abstract

Background. Viral hepatitis is a major burden for the healthcare system worldwide. Up to date, a comprehensive analysis of the prevalence of viral hepatitis in Kazakhstan and Central Asia has not been carried out yet. Our epidemiological study aimed at investigating the frequency and spread of viral hepatitis B, C, and D depending on age and sex in Kazakhstan (5-year period). Materials and Methods. We utilized the data from the primary registration of the incidence of hepatitis B, C, and D in 18 regions of Kazakhstan (period: from 2015 to 2020). Age indicators, gender, and territorial characteristics of registered cases were determined and analysed. The data were obtained from the state information system “Electronic Register of Dispensary Patients”, based on the International Classification of Diseases-10 for coding diseases. Results. During the period studied, 268 975 cases of hepatitis B, C, and D were detected in Kazakhstan. Hepatitis B was registered in n = 109 734 cases. In women, the incidence rate was 40.6% of all cases (n = 44545), and in men it was 59.4% (n = 65189) of all cases ( p ≤ 0.01 ). Hepatitis D was detected in 8 656 cases, of which 58.3% (n = 5049) were in men and 41.7% (n = 3607) in women ( p ≤ 0.01 ). Hepatitis C was registered in n = 159 585 cases. The rate was higher in the male population (54.6%; n = 82 203) compared to women 45.4% (n = 68382) ( p ≤ 0.01 ). In 2020 (in comparison with 2015), there was a significant increase in the incidence of hepatitis D by 68.3%, hepatitis B by 49.8%, and hepatitis C by 46.4%. The largest prevalence of hepatitis D was recorded in 2016 which is 22.3% higher compared to 2020. A significant increase in hepatitis C was recorded in 2019 compared to 2015, where indicators were 49.2% higher. Conclusion. An analysis of the prevalence of hepatitis B, C, and D showed an increase in new cases in Kazakhstan. These findings indicate the need to develop effective preventive measures and screening strategies among people in a high-risk group. The results of the study can be used for the development of a national program to combat the spread of viral hepatitis.

Evaluation of liver transplantation services in Kazakhstan from 2012 to 2023

“…However, the global etiology of liver cirrhosis has changed, moving away from viral hepatitis owing to the availability of effective antiviral medications and shifts in lifestyle and dietary approaches. In Kazakhstan, the burden of viral hepatitis is substantial and continues to grow, as indicated by our findings and earlier scientific data 23 . Direct-acting antiviral hepatitis C drugs have not gained widespread use in Kazakhstan, and despite antiviral hepatitis B vaccination being included in the national vaccination schedule in 1998, the prevalence of anti‐HBcore antibodies was reported to be 17.2%, surpassing rates in many other countries 24 .…”

Antibodies to Hepatitis B core antigen prevalence study in Kazakhstan

“…Kazakhstan is ranked as one of the countries with medium endemicity (2-7%) [17]. In 2020 about 23000 HBV cases were registered, the peak incidence was defined in West Kazakhstan, Kyzylorda region and Nur-Sultan city [18]. Approximately 21000 patients have CHB.…”

Liver Cancer Incidence in Kazakhstan: Fifteen-Year Retrospective Study

“…The recent study conducted by Jumabayeva et al in 2022 revealed a notable increase in new cases of hepatitis B, C, and D in Kazakhstan during the period of 2015-2020 [37]. This rise in hepatitis prevalence might heighten the necessity for an extensive approach to referring patients for liver cancer (LC) screening, as proposed by Harris et al in 2019 [38].…”